BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, Mayet J, Francis DP. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93:476-482. [PMID: 17005715 DOI: 10.1136/hrt.2006.089656] [Cited by in Crossref: 226] [Cited by in F6Publishing: 194] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Spruit MA, Wouters EF, Eterman RM, Meijer K, Wagers SS, Stakenborg KH, Uszko-Lencer NH. Task-related oxygen uptake and symptoms during activities of daily life in CHF patients and healthy subjects. Eur J Appl Physiol 2011;111:1679-86. [PMID: 21210281 DOI: 10.1007/s00421-010-1794-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
2 Braunschweig F, Linde C, Benson L, Ståhlberg M, Dahlström U, Lund LH. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy: NYHA class, QRS duration, and survival in HF. Eur J Heart Fail 2017;19:366-76. [DOI: 10.1002/ejhf.563] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
3 Stamp KD, Prasun MA, McCoy TP, Rathman L. Providers' assignment of NYHA functional class in patients with heart failure: A vignette study. Heart Lung 2021:S0147-9563(21)00228-4. [PMID: 34399995 DOI: 10.1016/j.hrtlng.2021.07.009] [Reference Citation Analysis]
4 Stamboulis E, Voumvouraki K, Zambelis T, Andrikopoulou A, Vlahakos D, Tsivgoulis A, Rallis D, Tsivgoulis G. There is No Association between Cardiovascular Autonomic Dysfunction and Peripheral Neuropathy in Chronic Hemodialysis Patients. J Clin Neurol 2010;6:143-7. [PMID: 20944815 DOI: 10.3988/jcn.2010.6.3.143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Sillen MJH, Speksnijder CM, Eterman RA, Janssen PP, Wagers SS, Wouters EFM, Uszko-Lencer NHMK, Spruit MA. Effects of neuromuscular electrical stimulation of muscles of ambulation in patients with chronic heart failure or COPD: a systematic review of the English-language literature. Chest 2009;136:44-61. [PMID: 19363213 DOI: 10.1378/chest.08-2481] [Cited by in Crossref: 108] [Cited by in F6Publishing: 86] [Article Influence: 8.3] [Reference Citation Analysis]
6 Van De Bruaene A, De Meester P, Voigt J, Delcroix M, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiéry J, Paelinck BP, Morissens M, Budts W. Worsening in oxygen saturation and exercise capacity predict adverse outcome in patients with Eisenmenger syndrome. International Journal of Cardiology 2013;168:1386-92. [DOI: 10.1016/j.ijcard.2012.12.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
7 Munief WM, Lu X, Teucke T, Wilhelm J, Britz A, Hempel F, Lanche R, Schwartz M, Law JKY, Grandthyll S, Müller F, Neurohr JU, Jacobs K, Schmitt M, Pachauri V, Hempelmann R, Ingebrandt S. Reduced graphene oxide biosensor platform for the detection of NT-proBNP biomarker in its clinical range. Biosens Bioelectron 2019;126:136-42. [PMID: 30399515 DOI: 10.1016/j.bios.2018.09.102] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
8 White-Williams C, Shirey M, Eagleson R, Clarkson S, Bittner V. An Interprofessional Collaborative Practice Can Reduce Heart Failure Hospital Readmissions and Costs in an Underserved Population. J Card Fail 2021:S1071-9164(21)00154-8. [PMID: 33991685 DOI: 10.1016/j.cardfail.2021.04.011] [Reference Citation Analysis]
9 Rezzoug N, Vaes B, Pasquet A, Gerber B, de Meester C, Van Pottelbergh G, Adriaensen W, Matheï C, DeGryse J, Vanoverschelde JL. Prevalence and Prognostic Impact of Valve Area-Gradient Patterns in Patients ≥80 Years With Moderate-to-Severe Aortic Stenosis (from the Prospective BELFRAIL Study). Am J Cardiol 2015;116:925-32. [PMID: 26219495 DOI: 10.1016/j.amjcard.2015.05.062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
10 Caraballo C, Desai NR, Mulder H, Alhanti B, Wilson FP, Fiuzat M, Felker GM, Piña IL, O'Connor CM, Lindenfeld J, Januzzi JL, Cohen LS, Ahmad T. Clinical Implications of the New York Heart Association Classification. J Am Heart Assoc 2019;8:e014240. [PMID: 31771438 DOI: 10.1161/JAHA.119.014240] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
11 Stamp KD, Prasun MA, McCoy TP, Rathman L. Providers' accuracy in decision-making with assessing NYHA functional class of patients with heart failure after use of a classification guide. Heart Lung 2022;54:85-94. [PMID: 35381418 DOI: 10.1016/j.hrtlng.2022.03.017] [Reference Citation Analysis]
12 Kidher E, Harling L, Ashrafian H, Naase H, Francis DP, Evans P, Athanasiou T. Aortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacement. J Cardiothorac Surg 2014;9:102. [PMID: 24938692 DOI: 10.1186/1749-8090-9-102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen W, Zheng L, Li K, Wang Q, Liu G, Jiang Q. A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement. PLoS One 2016;11:e0165304. [PMID: 27835634 DOI: 10.1371/journal.pone.0165304] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
14 Bizovičar N, Matjačić Z, Stanonik I, Goljar N. Overground gait training using a motorized assistive device in patients with severe disabilities after stroke. Int J Rehabil Res 2017;40:46-52. [PMID: 27779500 DOI: 10.1097/MRR.0000000000000199] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 O'Mahony C, Elliott P, McKenna W. Sudden cardiac death in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 2013;6:443-51. [PMID: 23022709 DOI: 10.1161/CIRCEP.111.962043] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
16 Li Y, Neilson MP, Whellan DJ, Schulman KA, Levy WC, Reed SD. Associations between Seattle Heart Failure Model scores and health utilities: findings from HF-ACTION. J Card Fail 2013;19:311-6. [PMID: 23663813 DOI: 10.1016/j.cardfail.2013.03.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
17 Titz M, Schwameis M, Kienbacher C, Buchtele N, Roth D, Duma A, Nagele P, Schörgenhofer C, Herkner H. Generalisability of randomised trials evaluating perioperative β-blocker therapy in noncardiac surgery. Br J Anaesth 2020;125:926-34. [PMID: 32888632 DOI: 10.1016/j.bja.2020.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Zhao W, Liu H, Feng R, Lin J. Pregnancy outcomes in women with Ebstein’s anomaly. Arch Gynecol Obstet 2012;286:881-8. [DOI: 10.1007/s00404-012-2386-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
19 Gist AC, Guymer EK, Ajani AE, Littlejohn GO. Fibromyalgia has a high prevalence and impact in cardiac failure patients. Eur J Rheumatol 2017;4:245-9. [PMID: 29308277 DOI: 10.5152/eurjrheum.2017.17026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Bilchick KC, Kamath S, DiMarco JP, Stukenborg GJ. Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation 2010;122:2022-30. [PMID: 21041691 DOI: 10.1161/CIRCULATIONAHA.110.956011] [Cited by in Crossref: 181] [Cited by in F6Publishing: 51] [Article Influence: 15.1] [Reference Citation Analysis]
21 Bratsos S. Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials. Cureus. 2019;11:e3913. [PMID: 30931184 DOI: 10.7759/cureus.3913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Son YJ, Kwon BE. Overactive Bladder is a Distress Symptom in Heart Failure. Int Neurourol J 2018;22:77-82. [PMID: 29991228 DOI: 10.5213/inj.1836120.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Grodin JL, Hammadah M, Fan Y, Hazen SL, Tang WH. Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail 2015;21:44-50. [PMID: 25175697 DOI: 10.1016/j.cardfail.2014.08.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
24 Girerd N, Seronde MF, Coiro S, Chouihed T, Bilbault P, Braun F, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Fillieux L, Abraham WT, Januzzi J Jr, Sebbag L, Zannad F, Mebazaa A, Rossignol P; INI-CRCT, Great Network, and the EF-HF Group. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart Fail 2018;6:273-85. [PMID: 29226815 DOI: 10.1016/j.jchf.2017.09.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
25 Williams BA, Doddamani S, Troup MA, Mowery AL, Kline CM, Gerringer JA, Faillace RT. Agreement between heart failure patients and providers in assessing New York Heart Association functional class. Heart Lung 2017;46:293-9. [PMID: 28558929 DOI: 10.1016/j.hrtlng.2017.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 van Riel AC, Schuuring MJ, van Hessen ID, Zwinderman AH, Cozijnsen L, Reichert CL, Hoorntje JC, Wagenaar LJ, Post MC, van Dijk AP, Hoendermis ES, Mulder BJ, Bouma BJ. Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification. Int J Cardiol 2014;174:299-305. [PMID: 24794056 DOI: 10.1016/j.ijcard.2014.04.072] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
27 Versteeg H, Denollet J, Meine M, Pedersen SS. Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays. Neth Heart J 2016;24:18-24. [PMID: 26645709 DOI: 10.1007/s12471-015-0775-5] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Jiang B, Yan L, Shamul JG, Hakun M, He X. Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering. Adv Ther (Weinh) 2020;3:1900182. [PMID: 33665356 DOI: 10.1002/adtp.201900182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
29 Pedersen SS, Herrmann-Lingen C, de Jonge P, Scherer M. Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class. J Behav Med. 2010;33:72-80. [PMID: 19937107 DOI: 10.1007/s10865-009-9236-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
30 Spertus JA, Jones PG. Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire. Circ Cardiovasc Qual Outcomes 2015;8:469-76. [PMID: 26307129 DOI: 10.1161/CIRCOUTCOMES.115.001958] [Cited by in Crossref: 129] [Cited by in F6Publishing: 80] [Article Influence: 21.5] [Reference Citation Analysis]
31 López-Candales A, Hernández Burgos PM, Vargas PE. New heart failure reclassification: are we left with more questions than answers? Postgrad Med 2018;130:449-51. [PMID: 29846126 DOI: 10.1080/00325481.2018.1481715] [Reference Citation Analysis]
32 Kempny A, Hjortshøj CS, Gu H, Li W, Opotowsky AR, Landzberg MJ, Jensen AS, Søndergaard L, Estensen M, Thilén U, Budts W, Mulder BJ, Blok I, Tomkiewicz-pająk L, Szostek K, D’alto M, Scognamiglio G, Prokšelj K, Diller G, Dimopoulos K, Wort SJ, Gatzoulis MA. Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study. Circulation 2017;135:1432-40. [DOI: 10.1161/circulationaha.116.023033] [Cited by in Crossref: 65] [Cited by in F6Publishing: 19] [Article Influence: 13.0] [Reference Citation Analysis]
33 Pedersen SS, Versteeg H, Denollet J, Cheng JM, Serruys PW, van Domburg RT. Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting. Qual Life Res 2011;20:559-67. [PMID: 20978857 DOI: 10.1007/s11136-010-9775-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
34 Parizo JT, Goldhaber-Fiebert JD, Salomon JA, Khush KK, Spertus JA, Heidenreich PA, Sandhu AT. Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction. JAMA Cardiol 2021;6:926-35. [PMID: 34037681 DOI: 10.1001/jamacardio.2021.1437] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Elkayam U. How to Predict Pregnancy Risk in an Individual Woman With Heart Disease. Journal of the American College of Cardiology 2018;71:2431-3. [DOI: 10.1016/j.jacc.2018.03.492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
36 Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, Zannad F, Maggioni AP, Swedberg K, Konstam MA, Spertus JA. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail 2010;12:367-74. [PMID: 20197265 DOI: 10.1093/eurjhf/hfq019] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
37 Maki N, Takahashi H, Nakata T, Wakayama S, Hasegawa D, Sakamoto H, Fujita Y, Takata Y, Sukada T, Sato Y, Yanagi H. The Effect of Respiratory Rehabilitation for the Frail Elderly: a Pilot Study. Journal of General and Family Medicine 2016;17:289-98. [DOI: 10.14442/jgfm.17.4_289] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
38 Hayward RA, Chen Y, Croft P, Jordan KP. Presentation of respiratory symptoms prior to diagnosis in general practice: a case-control study examining free text and morbidity codes. BMJ Open 2015;5:e007355. [PMID: 26070795 DOI: 10.1136/bmjopen-2014-007355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Nixdorff U, Drees M, von Bardeleben S, Mohr-kahaly S, Klinghammer L. Prognostication of post-infarct chronic heart failure: Superiority of clinical assessment vs. cardiopulmonary and left ventricular function analysis. International Journal of Cardiology 2009;132:187-96. [DOI: 10.1016/j.ijcard.2007.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
40 Bei Y, Yu P, Cretoiu D, Cretoiu SM, Xiao J. Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases. Adv Exp Med Biol 2017;998:71-88. [PMID: 28936733 DOI: 10.1007/978-981-10-4397-0_5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
41 Reina-Couto M, Carvalho J, Valente MJ, Vale L, Afonso J, Carvalho F, Bettencourt P, Sousa T, Albino-Teixeira A. Impaired resolution of inflammation in human chronic heart failure. Eur J Clin Invest 2014;44:527-38. [PMID: 24673112 DOI: 10.1111/eci.12265] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
42 Barst RJ, Chung L, Zamanian RT, Turner M, Mcgoon MD. Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry. Chest 2013;144:160-8. [DOI: 10.1378/chest.12-2417] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
43 Holmes DN, Piccini JP, Allen LA, Fonarow GC, Gersh BJ, Kowey PR, O’brien EC, Reiffel JA, Naccarelli GV, Ezekowitz MD, Chan PS, Singer DE, Spertus JA, Peterson ED, Thomas L; on behalf of the ORBIT-AF Investigators and Patients. Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. Circ: Cardiovascular Quality and Outcomes 2019;12. [DOI: 10.1161/circoutcomes.118.005358] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
44 Cascella M. Preoperative cardiac evaluation and anesthetic considerations for cancer patients who underwent chemotherapy. Trends in Anaesthesia and Critical Care 2017;14:9-18. [DOI: 10.1016/j.tacc.2017.03.002] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Sorgente A, Cappato R. A Critical Reappraisal of the Current Clinical Indications to Cardiac Resynchronisation Therapy. Arrhythm Electrophysiol Rev 2013;2:91-4. [PMID: 26835046 DOI: 10.15420/aer.2013.2.2.91] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Monzo L, Schiariti M, Calvisi PF, Bonfiglio S, Luštrek M, Puddu PE. Association of patient-reported outcomes and heart rate trends in heart failure: a report from the Chiron project. Sci Rep 2020;10:576. [PMID: 31953477 DOI: 10.1038/s41598-019-57239-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Kim CA, Rasania SP, Afilalo J, Popma JJ, Lipsitz LA, Kim DH. Functional status and quality of life after transcatheter aortic valve replacement: a systematic review. Ann Intern Med 2014;160:243-54. [PMID: 24727842 DOI: 10.7326/M13-1316] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
48 Taylor BJ, Mojica CR, Olson TP, Woods PR, Frantz RP, Johnson BD. A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure. J Card Fail 2013;19:50-9. [PMID: 23273594 DOI: 10.1016/j.cardfail.2012.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
49 Yamamoto K, Takeda Y, Takeda Y, Naniwa T, Narita H, Ohte N. Long-term survival of patients with pulmonary arterial hypertension recovering to World Health Organization functional class I or II: a historical comparison between intravenous epoprostenol and oral agents. BMC Res Notes 2014;7:359. [PMID: 24920465 DOI: 10.1186/1756-0500-7-359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Kim E, Kwon HY, Baek SH, Lee H, Yoo BS, Kang SM, Ahn Y, Yang BM. Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study. J Med Econ 2018;21:288-93. [PMID: 29125033 DOI: 10.1080/13696998.2017.1403922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
51 Zisis G, Huynh Q, Yang Y, Neil C, Carrington MJ, Ball J, Maguire G, Marwick TH. Rationale and design of a risk-guided strategy for reducing readmissions for acute decompensated heart failure: the Risk-HF study. ESC Heart Fail 2020;7:3151-60. [PMID: 32696559 DOI: 10.1002/ehf2.12897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Dalos D, Mascherbauer J, Zotter-Tufaro C, Duca F, Kammerlander AA, Aschauer S, Bonderman D. Functional Status, Pulmonary Artery Pressure, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2016;68:189-99. [PMID: 27386773 DOI: 10.1016/j.jacc.2016.04.052] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 11.2] [Reference Citation Analysis]
53 Kelkar AA, Spertus J, Pang P, Pierson RF, Cody RJ, Pina IL, Hernandez A, Butler J. Utility of Patient-Reported Outcome Instruments in Heart Failure. JACC: Heart Failure 2016;4:165-75. [DOI: 10.1016/j.jchf.2015.10.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
54 Plitt A, Dorbala S, Albert MA, Giugliano RP. Cardiac sarcoidosis: case report, workup, and review of the literature. Cardiol Ther 2013;2:181-97. [PMID: 25135396 DOI: 10.1007/s40119-013-0017-0] [Reference Citation Analysis]
55 Thibodeau JT, Mishkin JD, Patel PC, Mammen PP, Markham DW, Drazner MH. IIIB or Not IIIB: A Previously Unanswered Question. Journal of Cardiac Failure 2012;18:367-72. [DOI: 10.1016/j.cardfail.2012.01.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
56 Lyons KJ, Bischoff MK, Fonarow GC, Horwich TB. Noninvasive Bioelectrical Impedance for Predicting Clinical Outcomes in Outpatients With Heart Failure. Crit Pathw Cardiol 2017;16:32-6. [PMID: 28195941 DOI: 10.1097/HPC.0000000000000105] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
57 Zaharias E, Cataldo J, Mackin L, Howie-Esquivel J. Simple measures of function and symptoms in hospitalized heart failure patients predict short-term cardiac event-free survival. Nurs Res Pract. 2014;2014:815984. [PMID: 24672717 DOI: 10.1155/2014/815984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
58 Patel RB, Vaduganathan M, Greene SJ, Butler J. Nomenclature in heart failure: a call for objective, reproducible, and biologically-driven terminology. Eur J Heart Fail 2018;20:1379-81. [PMID: 29943879 DOI: 10.1002/ejhf.1231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Huitema AA, Harkness K, Heckman GA, Mckelvie RS. The Spoke-Hub-and-Node Model of Integrated Heart Failure Care. Canadian Journal of Cardiology 2018;34:863-70. [DOI: 10.1016/j.cjca.2018.04.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
60 Nassif ME, Tang Y, Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Daubert JC, Sherfesee L, Schaber D, Tang ASL, Jones PG, Arnold SV, Spertus JA. Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials. Circ Heart Fail 2017;10:e004111. [PMID: 29038172 DOI: 10.1161/CIRCHEARTFAILURE.117.004111] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
61 Pascual-Figal D, Bayes-Genis A. The misperception of 'stable' heart failure. Eur J Heart Fail 2018;20:1375-8. [PMID: 29943884 DOI: 10.1002/ejhf.1248] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
62 Di Tanna GL, Urbich M, Wirtz HS, Potrata B, Heisen M, Bennison C, Brazier J, Globe G. Health State Utilities of Patients with Heart Failure: A Systematic Literature Review. Pharmacoeconomics 2021;39:211-29. [PMID: 33251572 DOI: 10.1007/s40273-020-00984-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 de Jong S, van Veen TAB, de Bakker JMT, Vos MA, van Rijen HVM. Biomarkers of Myocardial Fibrosis: . Journal of Cardiovascular Pharmacology 2011;57:522-35. [DOI: 10.1097/fjc.0b013e31821823d9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
64 Thokala P, Dodd P, Baalbaki H, Brennan A, Dixon S, Lowrie K. Developing Markov Models From Real-World Data: A Case Study of Heart Failure Modeling Using Administrative Data. Value Health 2020;23:743-50. [PMID: 32540232 DOI: 10.1016/j.jval.2020.02.012] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Byun E, Kim J, Riegel B. Associations of Subjective Sleep Quality and Daytime Sleepiness With Cognitive Impairment in Adults and Elders With Heart Failure. Behav Sleep Med 2017;15:302-17. [PMID: 27116617 DOI: 10.1080/15402002.2015.1133418] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
66 Issa SM, Hoeks SE, Scholte op Reimer WJ, Van Gestel YR, Lenzen MJ, Verhagen HJ, Pedersen SS, Poldermans D. Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med 2010;15:163-9. [DOI: 10.1177/1358863x10364208] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
67 Cerier E, Lampert BC, Kilic A, McDavid A, Deo SV, Kilic A. To ventricular assist devices or not: When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure? World J Cardiol 2016; 8(12): 695-702 [PMID: 28070237 DOI: 10.4330/wjc.v8.i12.695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Laurent M, Fournet M, Feit B, Oger E, Donal E, Thébault C, Biron Y, Beneux X, Sellin M, Le Reveillé S, Flecher E, Leguerrier A. Simple bedside clinical evaluation versus established scores in the estimation of operative risk in valve replacement for severe aortic stenosis. Arch Cardiovasc Dis 2013;106:651-60. [PMID: 24231053 DOI: 10.1016/j.acvd.2013.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
69 Del Buono MG, Arena R, Borlaug BA, Carbone S, Canada JM, Kirkman DL, Garten R, Rodriguez-Miguelez P, Guazzi M, Lavie CJ, Abbate A. Exercise Intolerance in Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol 2019;73:2209-25. [PMID: 31047010 DOI: 10.1016/j.jacc.2019.01.072] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 43.0] [Reference Citation Analysis]
70 McEwan P, Darlington O, McMurray JJV, Jhund PS, Docherty KF, Böhm M, Petrie MC, Bergenheim K, Qin L. Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF. Eur J Heart Fail 2020;22:2147-56. [PMID: 32749733 DOI: 10.1002/ejhf.1978] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
71 Bagheri H, Yaghmaei F, Ashktorab T, Zayeri F. Test of a Dignity Model in patients with heart failure. Nurs Ethics 2018;25:532-46. [PMID: 27521243 DOI: 10.1177/0969733016658793] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
72 Di Giulio P; Network of Nurses of GISSI-HF. Should patients perception of health status be integrated in the prognostic assessment of heart failure patients? A prospective study. Qual Life Res 2014;23:49-56. [DOI: 10.1007/s11136-013-0468-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
73 Hawwa N, Vest AR, Kumar R, Lahoud R, Young JB, Wu Y, Gorodeski EZ, Cho L. Comparison Between the Kansas City Cardiomyopathy Questionnaire and New York Heart Association in Assessing Functional Capacity and Clinical Outcomes. Journal of Cardiac Failure 2017;23:280-5. [DOI: 10.1016/j.cardfail.2016.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
74 Ivanov A, Bhumireddy GP, Dabiesingh DS, Khan SA, Ho J, Krishna N, Dontineni N, Socolow JA, Briggs WM, Klem I, Sacchi TJ, Heitner JF. Importance of papillary muscle infarction detected by cardiac magnetic resonance imaging in predicting cardiovascular events. Int J Cardiol 2016;220:558-63. [PMID: 27390987 DOI: 10.1016/j.ijcard.2016.06.201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Aimo A, Barison A, Mammini C, Emdin M. The Barthel Index in elderly acute heart failure patients. Frailty matters. International Journal of Cardiology 2018;254:240-1. [DOI: 10.1016/j.ijcard.2017.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
76 Ben-Shoshan J, Zahler D, Margolis G, Arbel Y, Konigstein M, Chorin E, Steinvil A, Keren G, Banai S, Finkelstein A. Relation of Clinical Presentation of Aortic Stenosis and Survival Following Transcatheter Aortic Valve Implantation. Am J Cardiol 2019;123:961-6. [PMID: 30595395 DOI: 10.1016/j.amjcard.2018.12.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
77 Gravely S, Tamim H, Smith J, Daly T, Grace SL. Non-symptom-related factors contributing to delay in seeking medical care by patients with heart failure: a narrative review. J Card Fail 2011;17:779-87. [PMID: 21872149 DOI: 10.1016/j.cardfail.2011.05.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
78 Sandhu AT, Kohsaka S, Turakhia MP, Lewis EF, Heidenreich PA. Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction. JAMA Cardiol 2021. [PMID: 34757380 DOI: 10.1001/jamacardio.2021.4585] [Reference Citation Analysis]
79 Graven LJ, Martorella G, Gordon G, Grant Keltner JS, Higgins MK. Predictors of depression in outpatients with heart failure: An observational study. Int J Nurs Stud 2017;69:57-65. [PMID: 28182959 DOI: 10.1016/j.ijnurstu.2017.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
80 Hoekstra T, Jaarsma T, van Veldhuisen DJ, Hillege HL, Sanderman R, Lesman-Leegte I. Quality of life and survival in patients with heart failure. Eur J Heart Fail. 2013;15:94-102. [PMID: 22989869 DOI: 10.1093/eurjhf/hfs148] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
81 Carroll JD. The Benefits From TAVI: Mortality and beyond. Cathet Cardiovasc Intervent 2010;75:1127-8. [DOI: 10.1002/ccd.22630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Spertus J. Assessing patients' improvement in clinical trials. BMJ 2008;336:1258-9. [PMID: 18495633 DOI: 10.1136/bmj.39570.393218.BE] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
83 Mommersteeg PM, Denollet J, Spertus JA, Pedersen SS. Health status as a risk factor in cardiovascular disease: a systematic review of current evidence. Am Heart J 2009;157:208-18. [PMID: 19185627 DOI: 10.1016/j.ahj.2008.09.020] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 9.2] [Reference Citation Analysis]
84 Earl H, Hiller L, Vallier AL, Loi S, McAdam K, Hughes-Davies L, Rea D, Howe D, Raynes K, Higgins HB, Wilcox M, Plummer C, Mahler-Araujo B, Provenzano E, Chhabra A, Gasson S, Balmer C, Abraham JE, Caldas C, Hall P, Shinkins B, McCabe C, Hulme C, Miles D, Wardley AM, Cameron DA, Dunn JA. Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT. Health Technol Assess 2020;24:1-190. [PMID: 32880572 DOI: 10.3310/hta24400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Khan EU. Commentary on symptom experience of pulmonary arterial hypertension (PAH) patients. Clin Nurs Res 2011;20:135-43. [PMID: 21612023 DOI: 10.1177/1054773810395112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
86 Alkouri O, Hendriks JM, Magarey J, Schultz T. Predictors of Effective Self-care Interventions Among Jordanians With Heart Failure. Clin Nurs Res 2022;:10547738211068968. [PMID: 35135377 DOI: 10.1177/10547738211068968] [Reference Citation Analysis]
87 Guglin M, Barold SS. Evaluation of heart failure symptoms for device therapy. Pacing Clin Electrophysiol 2012;35:1045-9. [PMID: 22734857 DOI: 10.1111/j.1540-8159.2012.03457.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
88 Obrova J, Sovova E, Kocianova E, Taborsky M. Sudden cardiac death - a known unknown? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34782798 DOI: 10.5507/bp.2021.065] [Reference Citation Analysis]
89 Severo M, Gaio R, Lourenço P, Alvelos M, Bettencourt P, Azevedo A. Indirect calibration between clinical observers - application to the New York Heart Association functional classification system. BMC Res Notes 2011;4:276. [PMID: 21813014 DOI: 10.1186/1756-0500-4-276] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
90 Dimopoulos K, Diller G, Giannakoulas G, Petraco R, Chamaidi A, Karaoli E, Mullen M, Swan L, Piepoli MF, Poole-wilson PA, Francis DP, Gatzoulis MA. Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome. Journal of the American College of Cardiology 2009;54:2093-100. [DOI: 10.1016/j.jacc.2009.06.050] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
91 Plehn G, Vormbrock J, Meissner A, Trappe HJ. Effects of exercise on the duration of diastole and on interventricular phase differences in patients with hypertrophic cardiomyopathy: relationship to cardiac output reserve. J Nucl Cardiol 2009;16:233-43. [PMID: 19159996 DOI: 10.1007/s12350-008-9031-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
92 Chiurchiù V, Leuti A, Saracini S, Fontana D, Finamore P, Giua R, Padovini L, Incalzi RA, Maccarrone M. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes. FASEB j 2018;33:909-16. [DOI: 10.1096/fj.201801017r] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
93 Flox-Camacho A, Escribano-Subías P, Jiménez-López Guarch C, Fernández-Vaquero A, Martín-Ríos D, de la Calzada-Campo CS. Factors affecting the response to exercise in patients with severe pulmonary arterial hypertension. Arch Bronconeumol 2011;47:10-6. [PMID: 20889250 DOI: 10.1016/j.arbres.2010.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
94 Stevenson WG, Hernandez AF, Carson PE, Fang JC, Katz SD, Spertus JA, Sweitzer NK, Tang WH, Albert NM, Butler J, Westlake Canary CA, Collins SP, Colvin-Adams M, Ezekowitz JA, Givertz MM, Hershberger RE, Rogers JG, Teerlink JR, Walsh MN, Stough WG, Starling RC; Heart Failure Society of America Guideline Committee. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail. 2012;18:94-106. [PMID: 22300776 DOI: 10.1016/j.cardfail.2011.12.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 7.8] [Reference Citation Analysis]
95 Adam AM, Rizvi AH, Haq A, Naseem R, Rehan A, Shaikh AT, Abbas AH, Godil A, Ali A, Mallick MSA, Khan MS, Lashari MN. Prognostic value of blood count parameters in patients with acute coronary syndrome. Indian Heart J 2018;70:233-40. [PMID: 29716700 DOI: 10.1016/j.ihj.2017.06.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Muller G, Mercier E, Vignon P, Henry-Lagarrigue M, Kamel T, Desachy A, Botoc V, Plantefève G, Frat JP, Bellec F, Quenot JP, Dequin PF, Boulain T; Clinical Research in Intensive Care and Sepsis (CRICS) Group. Prognostic significance of central venous-to-arterial carbon dioxide difference during the first 24 hours of septic shock in patients with and without impaired cardiac function. Br J Anaesth 2017;119:239-48. [PMID: 28854537 DOI: 10.1093/bja/aex131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
97 Polikandrioti M, Panoutsopoulos G, Tsami A, Gerogianni G, Saroglou S, Thomai E, Leventzonis I. Assessment of quality of life and anxiety in heart failure outpatients. Arch Med Sci Atheroscler Dis 2019;4:e38-46. [PMID: 31211269 DOI: 10.5114/amsad.2019.84444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
98 Psotka MA, Fiuzat M, Carson PE, Kao DP, Cerkvenik J, Schaber DE, Verta P, Kazmierski RT, Shinnar M, Stockbridge N, Unger EF, Zuckerman B, Butler J, Felker GM, Konstam MA, Lindenfeld J, Solomon SD, Teerlink JR, O'Connor CM, Abraham WT. Design of a "Lean" Case Report Form for Heart Failure Therapeutic Development. JACC Heart Fail 2019;7:913-21. [PMID: 31401097 DOI: 10.1016/j.jchf.2019.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
99 Singhal A, Cowie MR. The Role of Wearables in Heart Failure. Curr Heart Fail Rep 2020;17:125-32. [PMID: 32494944 DOI: 10.1007/s11897-020-00467-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
100 Chicco D, Jurman G. Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone. BMC Med Inform Decis Mak 2020;20:16. [PMID: 32013925 DOI: 10.1186/s12911-020-1023-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 19] [Article Influence: 24.5] [Reference Citation Analysis]
101 Bredy C, Ministeri M, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Diller GP, Gatzoulis MA, Dimopoulos K. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. Eur Heart J Qual Care Clin Outcomes 2018;4:51-8. [PMID: 28950356 DOI: 10.1093/ehjqcco/qcx031] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 16.3] [Reference Citation Analysis]
102 Hiraiwa H, Okumura T, Murohara T. The cardiosplenic axis: the prognostic role of the spleen in heart failure. Heart Fail Rev 2022. [PMID: 35583622 DOI: 10.1007/s10741-022-10248-4] [Reference Citation Analysis]
103 Zecchin M, Proclemer A, Magnani S, Vitali-Serdoz L, Facchin D, Muser D, Nordio A, Barbati G, Puggia I, Sinagra G, Proclemer A. Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy. Europace 2014;16:363-71. [PMID: 24189477 DOI: 10.1093/europace/eut339] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
104 Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15:387-404. [PMID: 31209302 DOI: 10.1038/s41582-019-0210-4] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 31.0] [Reference Citation Analysis]
105 Wang C, Liu J, Xiao L, Liu D, Yan W, Hu T, Li K, Hua X, Zeng X. Comparison of FRAX in postmenopausal Asian women with and without type 2 diabetes mellitus: a retrospective observational study. J Int Med Res 2020;48:300060519879591. [PMID: 31617425 DOI: 10.1177/0300060519879591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes 2011;4:389-98. [PMID: 21693723 DOI: 10.1161/CIRCOUTCOMES.110.958009] [Cited by in Crossref: 85] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
107 Bagheri H, Yaghmaei F, Ashktorab T, Zayeri F. Relationship between illness-related worries and social dignity in patients with heart failure. Nurs Ethics 2018;25:618-27. [PMID: 27694547 DOI: 10.1177/0969733016664970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
108 Harky A, Kwok HT, Fan KS. The Evolution of Mitral Valve Surgery: the Future in the Hand of Robots. Braz J Cardiovasc Surg 2020;35:555-64. [PMID: 32864937 DOI: 10.21470/1678-9741-2019-0192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Castro RRT, Joyce E, Lakdawala NK, Stewart G, Nohria A, Givertz MM, Desai A, Lewis EF, Stevenson LW. Patients report more severe daily limitations than recognized by their physicians. Clin Cardiol 2019;42:1181-8. [PMID: 31571248 DOI: 10.1002/clc.23269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
110 Palau P, Domínguez E, Núñez E, Ramón JM, López L, Melero J, Sanchis J, Bellver A, Santas E, Bayes-Genis A, Chorro FJ, Núñez J. Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction. Rev Esp Cardiol (Engl Ed) 2018;71:250-6. [PMID: 28666951 DOI: 10.1016/j.rec.2017.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
111 van Boven N, Akkerhuis KM, Anroedh SS, Battes LC, Caliskan K, Yassi W, Manintveld OC, Cornel JH, Constantinescu AA, Boersma H, Umans VA, Kardys I. In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment. Neth Heart J 2017;25:634-42. [PMID: 28983818 DOI: 10.1007/s12471-017-1040-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Paoletti Perini A, Bartolini S, Pieragnoli P, Ricciardi G, Perrotta L, Valleggi A, Vergaro G, Michelotti F, Boggian G, Sassone B, Mascioli G, Emdin M, Padeletti L. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. Europace 2013;16:71-80. [DOI: 10.1093/europace/eut190] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
113 Lachowska K, Bellwon J, Narkiewicz K, Gruchała M, Hering D. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction. Clin Res Cardiol 2019;108:48-60. [PMID: 29943271 DOI: 10.1007/s00392-018-1310-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
114 Gundersen GH, Norekval TM, Haug HH, Skjetne K, Kleinau JO, Graven T, Dalen H. Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study. Heart 2016;102:29-34. [PMID: 26438785 DOI: 10.1136/heartjnl-2015-307798] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
115 Yap J, Lim FY, Gao F, Teo LL, Lam CS, Yeo KK. Correlation of the New York Heart Association Classification and the 6-Minute Walk Distance: A Systematic Review. Clin Cardiol 2015;38:621-8. [PMID: 26442458 DOI: 10.1002/clc.22468] [Cited by in Crossref: 43] [Cited by in F6Publishing: 29] [Article Influence: 6.1] [Reference Citation Analysis]
116 Watanabe H, Tanaka N, Inuta T, Saitou H, Yanagi H. Locomotion Improvement Using a Hybrid Assistive Limb in Recovery Phase Stroke Patients: A Randomized Controlled Pilot Study. Archives of Physical Medicine and Rehabilitation 2014;95:2006-12. [DOI: 10.1016/j.apmr.2014.07.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 8.9] [Reference Citation Analysis]
117 Garcia-Pavia P, Bengel F, Brito D, Damy T, Duca F, Dorbala S, Nativi-Nicolau J, Obici L, Rapezzi C, Sekijima Y, Elliott PM. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail 2021;23:895-905. [PMID: 33915002 DOI: 10.1002/ejhf.2198] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
118 Holland R, Rechel B, Stepien K, Harvey I, Brooksby I. Patients' self-assessed functional status in heart failure by New York Heart Association class: a prognostic predictor of hospitalizations, quality of life and death. J Card Fail 2010;16:150-6. [PMID: 20142027 DOI: 10.1016/j.cardfail.2009.08.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 5.6] [Reference Citation Analysis]
119 Jani BD, Mair FS, Roger VL, Weston SA, Jiang R, Chamberlain AM. Comorbid Depression and Heart Failure: A Community Cohort Study. PLoS One 2016;11:e0158570. [PMID: 27362359 DOI: 10.1371/journal.pone.0158570] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
120 Norine Walsh M, Bove AA, Cross RR, Ferdinand KC, Forman DE, Freeman AM, Hughes S, Klodas E, Koplan M, Lewis WR, Macdonnell B, May DC, Messer JV, Pressler SJ, Sanz ML, Spertus JA, Spinler SA, Evan Teichholz L, Wong JB, Doermann Byrd K. ACCF 2012 Health Policy Statement on Patient-Centered Care in Cardiovascular Medicine. Journal of the American College of Cardiology 2012;59:2125-43. [DOI: 10.1016/j.jacc.2012.03.016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
121 Attaran RR, Cavanaugh A, Tsay C, Ahmad T, Ochoa Chaar CI, Persing S, Hsia H. Safety of compression therapy for venous ulcer disease in the setting of congestive heart failure. Phlebology 2020;35:556-60. [PMID: 32028849 DOI: 10.1177/0268355520905178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Sui YB, Liu L, Tian QY, Deng XW, Zhang YQ, Li ZG. A retrospective study of traditional Chinese medicine as an adjunctive therapy for patients with chronic heart failure. Medicine (Baltimore) 2018;97:e11696. [PMID: 30045326 DOI: 10.1097/MD.0000000000011696] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
123 Maki N, Sakamoto H, Takata Y, Taniguchi K, Wijesinghe A, Okamura J, Kawamura T, Yanagihara T, Saeki Y, Kitazawa S, Kobayashi N, Kikuchi S, Goto Y, Ichimura H, Sato Y, Yanagi H. Effect of pulmonary training for community‐dwelling frail older adults with chronic stroke: A randomized controlled pilot trial. J Gen Fam Med. [DOI: 10.1002/jgf2.511] [Reference Citation Analysis]
124 Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care. Journal of the American College of Cardiology 2020;76:2379-90. [DOI: 10.1016/j.jacc.2020.09.542] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
125 Bradley SM, Strauss CE, Ho PM. Value in cardiovascular care. Heart 2017;103:1238-43. [DOI: 10.1136/heartjnl-2016-309753] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
126 El Missiri AM, Alzurfi AS, Keddeas VW. The Relationship between Tumor Necrosis Factor Alpha and Left Ventricular Diastolic Function. J Cardiovasc Echogr 2020;30:62-7. [PMID: 33282642 DOI: 10.4103/jcecho.jcecho_1_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Merchant FM, Zheng H, Bigger T, Steinman R, Ikeda T, Pedretti RF, Salerno-Uriarte JA, Klersy C, Chan PS, Bartone C, Hohnloser SH, Ruskin JN, Armoundas AA. A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J 2013;166:744-52. [PMID: 24093856 DOI: 10.1016/j.ahj.2013.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
128 Merchant FM, Levy WC, Kramer DB. Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use. J Am Heart Assoc 2020;9:e015139. [PMID: 32089058 DOI: 10.1161/JAHA.119.015139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
129 Hauptman PJ, Rich MW, Heidenreich PA, Chin J, Cummings N, Dunlap ME, Edwards ML, Gregory D, O'connor CM, Pezzella SM, Philbin E. The Heart Failure Clinic: A Consensus Statement of the Heart Failure Society of America. Journal of Cardiac Failure 2008;14:801-15. [DOI: 10.1016/j.cardfail.2008.10.005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
130 Lešnik A, Piko N, Železnik D, Bevc S. Dehydration of Older Patients in Institutional Care and the Home Environment. Research in Gerontological Nursing 2017;10:260-6. [DOI: 10.3928/19404921-20171013-03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
131 Allen LA, Spertus JA. End points for comparative effectiveness research in heart failure. Heart Fail Clin 2013;9:15-28. [PMID: 23168314 DOI: 10.1016/j.hfc.2012.09.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
132 Scerrino G, Melfa G, Lo Brutto D, Mazzola S, Corigliano A, Vitale I, Tutino R, Rotolo G, Orlando G, Cocorullo G. Chronic asthenia in patients who have undergone endocrine neck surgery. Endocrine 2021. [PMID: 34365588 DOI: 10.1007/s12020-021-02838-3] [Reference Citation Analysis]
133 Altara R, Manca M, Hessel MH, Gu Y, van Vark LC, Akkerhuis KM, Staessen JA, Struijker-Boudier HA, Booz GW, Blankesteijn WM. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study. J Cardiovasc Transl Res 2016;9:302-14. [PMID: 27271043 DOI: 10.1007/s12265-016-9703-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
134 Howie-Esquivel J, Zaharias E. Using Novel Technology to Determine Mobility Among Hospitalized Heart Failure Patients: A Pilot Study. Cardiol Res 2013;4:15-25. [PMID: 28348698 DOI: 10.4021/cr244w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
135 Kane PM, Murtagh FEM, Ryan KR, Brice M, Mahon NG, McAdam B, McQuillan R, O'Gara G, Raleigh C, Tracey C, Howley C, Higginson IJ, Daveson BA; BuildCARE. Strategies to address the shortcomings of commonly used advanced chronic heart failure descriptors to improve recruitment in palliative care research: A parallel mixed-methods feasibility study. Palliat Med 2018;32:517-24. [PMID: 28488925 DOI: 10.1177/0269216317706426] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
136 Cuthbert JJ, Pellicori P, Clark AL. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update. Med Devices (Auckl) 2017;10:123-32. [PMID: 28652826 DOI: 10.2147/MDER.S113105] [Reference Citation Analysis]
137 Dias KJ. Best Practice for Home Physical Therapy for Older Adults with Heart Failure. Curr Geri Rep 2018;7:71-9. [DOI: 10.1007/s13670-018-0239-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Alosco ML, Spitznagel MB, Cohen R, Sweet LH, Josephson R, Hughes J, Rosneck J, Gunstad J. Better adherence to treatment recommendations in heart failure predicts improved cognitive function at a one-year follow-up. J Clin Exp Neuropsychol 2014;36:956-66. [PMID: 25352233 DOI: 10.1080/13803395.2014.957167] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
139 Albuquerque de Almeida F, Al MJ, Koymans R, Riistama J, Pauws S, Severens JL. Impact of hospitalisation on health-related quality of life in patients with chronic heart failure. Health Qual Life Outcomes 2020;18:262. [PMID: 32746842 DOI: 10.1186/s12955-020-01508-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
140 Chivite D, Formiga F, Pujol R. La insuficiencia cardíaca en el paciente anciano. Revista Clínica Española 2011;211:26-35. [DOI: 10.1016/j.rce.2010.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
141 Hejjaji V, Tang Y, Coles T, Jones PG, Reeve BB, Mentz RJ, Spatz ES, Dunlay SM, Caldwell B, Saha A, Tarver ME, Tran A, Patel KK, Henke D, Piña IL, Spertus JA. Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure. Circ Heart Fail 2021;14:e008284. [PMID: 34465123 DOI: 10.1161/CIRCHEARTFAILURE.120.008284] [Reference Citation Analysis]
142 Källström M, Soveri I, Oldgren J, Laukkanen J, Ichiki T, Tei C, Timmerman M, Berglund L, Hägglund H. Effects of sauna bath on heart failure: A systematic review and meta-analysis. Clin Cardiol 2018;41:1491-501. [PMID: 30239008 DOI: 10.1002/clc.23077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
143 Gallagher AM, Lucas R, Cowie MR. Assessing health-related quality of life in heart failure patients attending an outpatient clinic: a pragmatic approach. ESC Heart Fail 2019;6:3-9. [PMID: 30311454 DOI: 10.1002/ehf2.12363] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
144 Cascino TM, Aaronson KD, Stewart GC. Identifying Stage D Heart Failure: Data From the Most Recent Registries. Curr Heart Fail Rep 2019;16:130-9. [PMID: 31250278 DOI: 10.1007/s11897-019-00433-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Mehta S, Mehta N, Tang WH, Young J. Cardiologists' Perception of Wearable Device Data in Patients with Heart Failure. J Gen Intern Med 2020;35:940-1. [PMID: 31898121 DOI: 10.1007/s11606-019-05390-z] [Reference Citation Analysis]
146 Hu Y, Jiang S, Lu S, Xu R, Huang Y, Zhao Z, Qu Y. Echocardiography and Electrocardiography Variables Correlate With the New York Heart Association classification: An Observational Study of Ischemic Cardiomyopathy Patients. Medicine (Baltimore) 2017;96:e7071. [PMID: 28658100 DOI: 10.1097/MD.0000000000007071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
147 Baril JF, Bromberg S, Moayedi Y, Taati B, Manlhiot C, Ross HJ, Cafazzo J. Use of Free-Living Step Count Monitoring for Heart Failure Functional Classification: Validation Study. JMIR Cardio 2019;3:e12122. [PMID: 31758777 DOI: 10.2196/12122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
148 Blanchard V, Courtellemont C, Cariou E, Fournier P, Lavie-badie Y, Pascal P, Galinier M, Kamar N, Carrié D, Lairez O. Cardiac impact of arteriovenous fistulas: what tools to assess? Heart Vessels 2020;35:1583-93. [DOI: 10.1007/s00380-020-01630-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Wang XH, Qiu JB, Ju Y, Chen GC, Yang JH, Pang JH, Zhao X. Reduction of heart failure rehospitalization using a weight management education intervention. J Cardiovasc Nurs 2014;29:528-34. [PMID: 24088617 DOI: 10.1097/JCN.0000000000000092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
150 Neyt M, Van den Bruel A, Smit Y, De Jonge N, Erasmus M, Van Dijk D, Vlayen J. Cost-effectiveness of continuous-flow left ventricular assist devices. Int J Technol Assess Health Care 2013;29:254-60. [PMID: 23763844 DOI: 10.1017/S0266462313000238] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
151 Xu CC, Fu GX, Liu QQ, Zhong Y. Association between cystatin C and heart failure with preserved ejection fraction in elderly Chinese patients. Z Gerontol Geriatr 2018;51:92-7. [PMID: 27206415 DOI: 10.1007/s00391-016-1058-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
152 Versteeg H, Schiffer AA, Widdershoven JW, Meine MM, Doevendans PA, Pedersen SS. Response to cardiac resynchronization therapy: is it time to expand the criteria? Pacing Clin Electrophysiol 2009;32:1247-56. [PMID: 19702599 DOI: 10.1111/j.1540-8159.2009.02505.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
153 Moayedi Y, Abdulmajeed R, Duero Posada J, Foroutan F, Alba AC, Cafazzo J, Ross HJ. Assessing the Use of Wrist-Worn Devices in Patients With Heart Failure: Feasibility Study. JMIR Cardio 2017;1:e8. [PMID: 31758789 DOI: 10.2196/cardio.8301] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
154 Greene SJ, Adusumalli S, Albert NM, Hauptman PJ, Rich MW, Heidenreich PA, Butler J; Heart Failure Society of America Quality of Care Committee. Building a Heart Failure Clinic: A Practical Guide from the Heart Failure Society of America. J Card Fail 2021;27:2-19. [PMID: 33289664 DOI: 10.1016/j.cardfail.2020.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Nozaki K, Kamiya K, Hamazaki N, Saito H, Saito K, Ogasahara Y, Maekawa E, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Makino A, Oka K, Momomura SI, Kagiyama N, Matsue Y. Validity and Utility of the Questionnaire-based FRAIL Scale in Older Patients with Heart Failure: Findings from the FRAGILE-HF. J Am Med Dir Assoc 2021;22:1621-1626.e2. [PMID: 33785309 DOI: 10.1016/j.jamda.2021.02.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Kajimoto K, Sato N; Investigators of the Acute Decompensated Heart Failure Syndromes (ATTEND) Registry. Sex Differences in New York Heart Association Functional Classification and Survival in Acute Heart Failure Patients With Preserved or Reduced Ejection Fraction. Can J Cardiol 2020;36:30-6. [PMID: 31759787 DOI: 10.1016/j.cjca.2019.08.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
157 Doing-Harris K, Bray BE, Thackeray A, Shah RU, Shao Y, Cheng Y, Zeng-Treitler Q, Garvin JH, Weir C. Development of a cardiac-centered frailty ontology. J Biomed Semantics 2019;10:3. [PMID: 30658684 DOI: 10.1186/s13326-019-0195-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
158 Palau P, Domínguez E, Núñez E, Ramón JM, López L, Melero J, Sanchis J, Bellver A, Santas E, Bayes-genis A, Chorro FJ, Núñez J. El consumo máximo de oxígeno predice los ingresos recurrentes por insuficiencia cardiaca con fracción de eyección conservada. Revista Española de Cardiología 2018;71:250-6. [DOI: 10.1016/j.recesp.2017.05.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
159 Bagheri H, Yaghmaei F, Ashktorab T, Zayeri F. Patient dignity and its related factors in heart failure patients. Nurs Ethics 2012;19:316-27. [DOI: 10.1177/0969733011425970] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
160 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2021.12.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
161 Wei XJ, Han M, Yang FY, Wei GC, Liang ZG, Yao H, Ji CW, Xie RS, Gong CL, Tian Y. Biological significance of miR-126 expression in atrial fibrillation and heart failure. Braz J Med Biol Res 2015;48:983-9. [PMID: 26313139 DOI: 10.1590/1414-431X20154590] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
162 Iliadis C, Lee S, Kuhr K, Metze C, Matzik A, Michels G, Rudolph V, Baldus S, Pfister R. Functional status and quality of life after transcatheter mitral valve repair: a prospective cohort study and systematic review. Clin Res Cardiol 2017;106:1005-17. [DOI: 10.1007/s00392-017-1150-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
163 Schichtel M, Wee B, Perera R, Onakpoya I. The Effect of Advance Care Planning on Heart Failure: a Systematic Review and Meta-analysis. J Gen Intern Med 2020;35:874-84. [PMID: 31720968 DOI: 10.1007/s11606-019-05482-w] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
164 El Missiri A, Amin SA, Tawfik IR, Shabana AM. Effect of a 6-week and 12-week cardiac rehabilitation program on heart rate recovery. Egypt Heart J 2020;72:69. [PMID: 33052491 DOI: 10.1186/s43044-020-00107-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Gerlach Y, Williams MT, Coates AM. Weighing up the evidence–a systematic review of measures used for the sensation of breathlessness in obesity. Int J Obes 2013;37:341-9. [DOI: 10.1038/ijo.2012.49] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
166 Earl HM, Vallier AL, Dunn J, Loi S, Ogburn E, McAdam K, Hughes-Davies L, Harnett A, Abraham J, Wardley A, Cameron DA, Miles D, Gounaris I, Plummer C, Hiller L. Trastuzumab-associated cardiac events in the Persephone trial. Br J Cancer 2016;115:1462-70. [PMID: 27875516 DOI: 10.1038/bjc.2016.357] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
167 Alamri A, Burzangi AS, Coats P, Watson DG. Untargeted Metabolic Profiling Cell-Based Approach of Pulmonary Artery Smooth Muscle Cells in Response to High Glucose and the Effect of the Antioxidant Vitamins D and E. Metabolites 2018;8:E87. [PMID: 30513640 DOI: 10.3390/metabo8040087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
168 Lombard KA. Physical Therapy for a Child Poststroke With a Left Ventricular Assist Device. Pediatric Physical Therapy 2016;28:126-32. [DOI: 10.1097/pep.0000000000000225] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
169 Bayes-Genis A, Núñez J. Step by Step Toward Biomarker-Based Precision Medicine in Heart Failure. Clin Chem 2019;65:1187-9. [PMID: 31362933 DOI: 10.1373/clinchem.2019.308478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
170 Vikholm P, Ivert T, Nilsson J, Holmgren A, Freter W, Ternström L, Ghaidan H, Sartipy U, Olsson C, Granfeldt H, Ragnarsson S, Friberg Ö. Validity of the Swedish Cardiac Surgery Registry. Interact Cardiovasc Thorac Surg 2018;27:67-74. [PMID: 29452368 DOI: 10.1093/icvts/ivy030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
171 Hertzog MA, Pozehl B, Duncan K. Cluster Analysis of Symptom Occurrence to Identify Subgroups of Heart Failure Patients: A Pilot Study. Journal of Cardiovascular Nursing 2010;25:273-83. [DOI: 10.1097/jcn.0b013e3181cfbb6c] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
172 Barco S, Russo M, Vicaut E, Becattini C, Bertoletti L, Beyer-Westendorf J, Bouvaist H, Couturaud F, Danays T, Dellas C, Duerschmied D, Empen K, Ferrari E, Galiè N, Jiménez D, Klok FA, Kostrubiec M, Kozak M, Kupatt C, Lang IM, Lankeit M, Meneveau N, Palazzini M, Pruszczyk P, Rugolotto M, Salvi A, Sanchez O, Schellong S, Sobkowicz B, Meyer G, Konstantinides SV. Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Clin Res Cardiol 2019;108:772-8. [PMID: 30564950 DOI: 10.1007/s00392-018-1405-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
173 Grafton G, Cascino TM, Perry D, Ashur C, Koelling TM. Resting Oxygen Consumption and Heart Failure: Importance of Measurement for Determination of Cardiac Output With the Use of the Fick Principle. J Card Fail 2020;26:664-72. [PMID: 30753933 DOI: 10.1016/j.cardfail.2019.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 Bagur R, Rodés-Cabau J, Dumont E, De Larochellière R, Doyle D, Pibarot P, Côté M, Clavel MA, Villeneuve J, Gutiérrez M, Poirier P, Bertrand OF. Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation. Am Heart J 2011;161:726-34. [PMID: 21473972 DOI: 10.1016/j.ahj.2010.12.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
175 Chavanon ML, Inkrot S, Zelenak C, Tahirovic E, Stanojevic D, Apostolovic S, Sljivic A, Ristic AD, Matic D, Loncar G, Veskovic J, Zdravkovic M, Lainscak M, Pieske B, Herrmann-Lingen C, Düngen HD. Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial. Clin Res Cardiol 2017;106:645-55. [PMID: 28361371 DOI: 10.1007/s00392-017-1101-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
176 Goode KM, Nabb S, Cleland JG, Clark AL. A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. J Card Fail 2008;14:379-87. [PMID: 18514929 DOI: 10.1016/j.cardfail.2008.01.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
177 Coles TM, Hernandez AF, Reeve BB, Cook K, Edwards MC, Boutin M, Bush E, Degboe A, Roessig L, Rudolph A, McNulty P, Patel N, Kay-Mugford T, Vernon M, Woloschak M, Buchele G, Spertus JA, Roe MT, Bury D, Weinfurt K. Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials. Health Qual Life Outcomes 2021;19:164. [PMID: 34120618 DOI: 10.1186/s12955-021-01800-1] [Reference Citation Analysis]
178 Papadimitriou L, Moore CK, Butler J, Long RC. The Limitations of Symptom-based Heart Failure Management. Card Fail Rev 2019;5:74-7. [PMID: 31179015 DOI: 10.15420/cfr.2019.3.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
179 Shang X, Xiao S, Dong N, Lu R, Wang L, Wang B, Chen Y, Zhong L, Liu M. Assessing right ventricular function in pulmonary hypertension patients and the correlation with the New York Heart Association (NYHA) classification. Oncotarget 2017;8:90421-9. [PMID: 29163841 DOI: 10.18632/oncotarget.19026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
180 Parker MS, Fahrner LJ, Deuell BPF, Olsen KM, Kasirajan V, Shah KB, Medina AE, Doolin KR, de Groot PA, Goodman WC. Total Artificial Heart Implantation: Clinical Indications, Expected Postoperative Imaging Findings, and Recognition of Complications. American Journal of Roentgenology 2014;202:W191-201. [DOI: 10.2214/ajr.13.11066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
181 Allen LA. End-point selection for acute heart failure trials. Heart Fail Clin 2011;7:481-95. [PMID: 21925431 DOI: 10.1016/j.hfc.2011.06.007] [Reference Citation Analysis]
182 Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol 2012;109:729-35. [PMID: 22176998 DOI: 10.1016/j.amjcard.2011.10.033] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
183 Shoemaker MJ, Dias KJ, Lefebvre KM, Heick JD, Collins SM. Physical Therapist Clinical Practice Guideline for the Management of Individuals With Heart Failure. Phys Ther 2020;100:14-43. [PMID: 31972027 DOI: 10.1093/ptj/pzz127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
184 Auguste BL, Agarwal A, Ibrahim AZ, Girsberger MY, Abreu Z, McQuillan RF, Bargman JM. A Single-Center Retrospective Study on the Initiation of Peritoneal Dialysis in Patients With Cardiorenal Syndrome and Subsequent Hospitalizations. Can J Kidney Health Dis 2020;7:2054358120979239. [PMID: 33343912 DOI: 10.1177/2054358120979239] [Reference Citation Analysis]
185 Cosiano MF, Tobin R, Mentz RJ, Greene SJ. Physical Functioning in Heart Failure With Preserved Ejection Fraction. J Card Fail 2021:S1071-9164(21)00156-1. [PMID: 33991684 DOI: 10.1016/j.cardfail.2021.04.013] [Reference Citation Analysis]
186 Gil-Rojas Y, Lasalvia P, García Á. Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia. Expert Rev Pharmacoecon Outcomes Res 2021;:1-9. [PMID: 34702123 DOI: 10.1080/14737167.2022.1997595] [Reference Citation Analysis]
187 Scerrino G, Melfa G, Raspanti C, Attard A, Mazzola S, Gullo R, Bonventre S, Attard M, Cocorullo G, Gulotta G. The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbecks Arch Surg 2017;402:1095-102. [PMID: 28299450 DOI: 10.1007/s00423-017-1568-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
188 Psotka MA, von Maltzahn R, Anatchkova M, Agodoa I, Chau D, Malik FI, Patrick DL, Spertus JA, Wiklund I, Teerlink JR. Patient-Reported Outcomes in Chronic Heart Failure: Applicability for Regulatory Approval. JACC Heart Fail 2016;4:791-804. [PMID: 27395351 DOI: 10.1016/j.jchf.2016.04.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
189 Albuquerque FN, Brandão AA, Silva DA, Rocha RM, Bittencourt MI, Sales ALF, Spineti PPM, Duque GS, Azevedo LRS, Pozzan R, Tura BR, Albuquerque DC. Ser49Gly Beta1-Adrenergic Receptor Genetic Polymorphism as a Death Predictor in Brazilian Patients with Heart Failure. Arq Bras Cardiol 2020;114:616-24. [PMID: 32491001 DOI: 10.36660/abc.20190187] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Yuan S, Schmidt HM, Wood KC, Straub AC. CoenzymeQ in cellular redox regulation and clinical heart failure. Free Radical Biology and Medicine 2021;167:321-34. [DOI: 10.1016/j.freeradbiomed.2021.03.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 R Schatz B. Population measurement for health systems. NPJ Digit Med 2018;1:20174. [PMID: 31304348 DOI: 10.1038/s41746-017-0004-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
192 Severino P, D’amato A, Prosperi S, Dei Cas A, Mattioli AV, Cevese A, Novo G, Prat M, Pedrinelli R, Raddino R, Gallina S, Schena F, Poggesi C, Pagliaro P, Mancone M, Fedele F; on behalf of the Italian National Institute for Cardiovascular Research (INRC). Do the Current Guidelines for Heart Failure Diagnosis and Treatment Fit with Clinical Complexity? JCM 2022;11:857. [DOI: 10.3390/jcm11030857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
193 Gotzmann M, Bojara W, Lindstaedt M, Ewers A, Bösche L, Germing A, Lawo T, Bechtel M, Laczkovics A, Mügge A. One-year results of transcatheter aortic valve implantation in severe symptomatic aortic valve stenosis. Am J Cardiol 2011;107:1687-92. [PMID: 21439537 DOI: 10.1016/j.amjcard.2011.01.058] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
194 Wang CH, Cheng ML, Liu MH, Fu TC. Amino Acid-Based Metabolic Profile Provides Functional Assessment and Prognostic Value for Heart Failure Outpatients. Dis Markers 2019;2019:8632726. [PMID: 31236145 DOI: 10.1155/2019/8632726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
195 Arvanitaki A, Michou E, Kalogeropoulos A, Karvounis H, Giannakoulas G. Mildly symptomatic heart failure with reduced ejection fraction: diagnostic and therapeutic considerations. ESC Heart Fail 2020;7:1477-87. [PMID: 32368873 DOI: 10.1002/ehf2.12701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Greene SJ, Butler J, Spertus JA, Hellkamp AS, Vaduganathan M, DeVore AD, Albert NM, Duffy CI, Patterson JH, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction. JAMA Cardiol 2021;6:522-31. [PMID: 33760037 DOI: 10.1001/jamacardio.2021.0372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Ritt LEF, Ribeiro RS, Souza IPMAD, Ramos JVSP, Ribeiro DS, Feitosa GF, Oliveira QBD, Stein R, Darzé ES. Baixa Concordância entre a Classificação da NYHA e as Variáveis do Teste de Exercício Cardiopulmonar em Pacientes com Insuficiência Cardíaca e Fração de Ejeção Reduzida. Arquivos Brasileiros de Cardiologia 2022. [DOI: 10.36660/abc.20210222] [Reference Citation Analysis]
198 Lim FY, Yap J, Gao F, Teo LL, Lam CS, Yeo KK. Correlation of the New York Heart Association classification and the cardiopulmonary exercise test: A systematic review. International Journal of Cardiology 2018;263:88-93. [DOI: 10.1016/j.ijcard.2018.04.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
199 Peeters JM, Sanders-van Wijk S, Bektas S, Knackstedt C, Rickenbacher P, Nietlispach F, Handschin R, Maeder MT, Muzzarelli SF, Pfisterer ME, Brunner-La Rocca HP. Biomarkers in outpatient heart failure management; Are they correlated to and do they influence clinical judgment? Neth Heart J 2014;22:115-21. [PMID: 24338787 DOI: 10.1007/s12471-013-0503-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
200 Guo H, Wang M, Zhao J, Liu J, Yang JM. Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure. J Geriatr Cardiol 2018;15:41-9. [PMID: 29434624 DOI: 10.11909/j.issn.1671-5411.2018.01.010] [Reference Citation Analysis]
201 Biton Y, Rosero S, Moss A, Zareba W, Kutyifa V, Baman J, Barsheshet A, McNitt S, Polonsky B, Goldenberg I. Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure. Am J Cardiol 2018;121:615-20. [PMID: 29307459 DOI: 10.1016/j.amjcard.2017.11.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
202 Sawadogo K, Ambroise J, Vercauteren S, Castadot M, Vanhalewyn M, Col J, Robert A. Interaction between the Kansas City Cardiomyopathy Questionnaire and the Pocock's clinical score in predicting heart failure outcomes. Qual Life Res 2016;25:1245-55. [PMID: 26456163 DOI: 10.1007/s11136-015-1154-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Han J, Chung F, Nguyen QL, Mody FV, Jackevicius CA. Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System. Pharmacotherapy 2019;39:1053-9. [DOI: 10.1002/phar.2328] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
204 El Missiri AM, Awadalla HM, Almoudi MM. Gender differences among ischemic heart disease patients enrolled in a cardiac rehabilitation program. Egypt Heart J 2020;72:15. [PMID: 32232591 DOI: 10.1186/s43044-020-00052-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Di Tanna GL, Bychenkova A, O'Neill F, Wirtz HS, Miller P, Ó Hartaigh B, Globe G. Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review. Pharmacoeconomics 2019;37:359-89. [PMID: 30596210 DOI: 10.1007/s40273-018-0755-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
206 Thompson LE, Bekelman DB, Allen LA, Peterson PN. Patient-Reported Outcomes in Heart Failure: Existing Measures and Future Uses. Curr Heart Fail Rep 2015;12:236-46. [DOI: 10.1007/s11897-015-0253-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
207 Spertus JA. Evolving applications for patient-centered health status measures. Circulation 2008;118:2103-10. [PMID: 19001034 DOI: 10.1161/CIRCULATIONAHA.107.747568] [Cited by in Crossref: 124] [Cited by in F6Publishing: 61] [Article Influence: 8.9] [Reference Citation Analysis]
208 Vuckovic KM, Fink AM. The 6-min walk test: is it an effective method for evaluating heart failure therapies? Biol Res Nurs 2012;14:147-59. [PMID: 21586495 DOI: 10.1177/1099800411403918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
209 Tahara N, Dobashi H, Fukuda K, Funauchi M, Hatano M, Ikeda S, Joho S, Kihara Y, Kondo T, Matsushita M, Minamino T, Nakanishi N, Okano Y, Ozaki Y, Saji T, Sakai S, Tanabe N, Watanabe H, Yamada H, Yoshioka K, Hatta M, Sasayama S. Long-term treatment of pulmonary arterial hypertension with macitentan in Japanese patients. Curr Med Res Opin 2020;36:921-8. [PMID: 32298185 DOI: 10.1080/03007995.2020.1756234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Szczurek W, Szyguła-Jurkiewicz B, Siedlecki Ł, Gąsior M. Prognostic scales in advanced heart failure. Kardiochir Torakochirurgia Pol 2018;15:183-7. [PMID: 30310398 DOI: 10.5114/kitp.2018.78444] [Reference Citation Analysis]
211 Montero D, Flammer AJ. Effect of Beta-blocker Treatment on V˙O2peak in Patients with Heart Failure. Medicine & Science in Sports & Exercise 2018;50:889-96. [DOI: 10.1249/mss.0000000000001513] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
212 Favoccia C, Kempny A, Yorke J, Armstrong I, Price LC, McCabe C, Harries C, Wort SJ, Dimopoulos K. EmPHasis-10 score for the assessment of quality of life in various types of pulmonary hypertension and its relation to outcome. Eur J Prev Cardiol 2019;26:1338-40. [PMID: 30567456 DOI: 10.1177/2047487318819161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
213 Tjam EY, Heckman GA, Smith S, Arai B, Hirdes J, Poss J, McKelvie RS. Predicting heart failure mortality in frail seniors: comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0. Int J Cardiol 2012;155:75-80. [PMID: 21292334 DOI: 10.1016/j.ijcard.2011.01.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
214 Omar M, Jensen J, Frederiksen PH, Videbæk L, Poulsen MK, Brønd JC, Gustafsson F, Borlaug BA, Schou M, Møller JE. Hemodynamic Determinants of Activity Measured by Accelerometer in Patients With Stable Heart Failure. JACC Heart Fail 2021;9:824-35. [PMID: 34509409 DOI: 10.1016/j.jchf.2021.05.013] [Reference Citation Analysis]
215 Li Y, Fitzgibbons TP, McManus DD, Goddeau RP Jr, Silver B, Henninger N. Left Ventricular Ejection Fraction and Clinically Defined Heart Failure to Predict 90-Day Functional Outcome After Ischemic Stroke. J Stroke Cerebrovasc Dis 2019;28:371-80. [PMID: 30396839 DOI: 10.1016/j.jstrokecerebrovasdis.2018.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
216 Wohlfahrt P, Stehlik J, Pan IZ, Ryan JJ. Empowering People Living with Heart Failure. Heart Fail Clin 2020;16:409-20. [PMID: 32888636 DOI: 10.1016/j.hfc.2020.06.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Komlo C, Mori M, Geirsson A. Commentary: Excellent outcome for mitral valve repair in asymptomatic patients-Does the surgery benefit the patient? J Thorac Cardiovasc Surg 2021;161:995-6. [PMID: 33461805 DOI: 10.1016/j.jtcvs.2020.12.064] [Reference Citation Analysis]
218 Kempny A, Dimopoulos K, Alonso-gonzalez R, Alvarez-barredo M, Tutarel O, Uebing A, Piatek P, Marino P, Swan L, Diller G, Wort SJ, Gatzoulis MA. Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndrome. International Journal of Cardiology 2013;168:4784-9. [DOI: 10.1016/j.ijcard.2013.07.227] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
219 Kane PM, Daveson BA, Ryan K, Ellis-Smith CI, Mahon NG, McAdam B, McQuilllan R, Tracey C, Howley C, O'Gara G, Raleigh C, Higginson IJ, Koffman J, Murtagh FEM; BuildCARE. Feasibility and acceptability of a patient-reported outcome intervention in chronic heart failure. BMJ Support Palliat Care 2017;7:470-9. [PMID: 28864449 DOI: 10.1136/bmjspcare-2017-001355] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]